Rocco Basciano, MD
Geriatric Medicine · Newport News, VANPI 1952484651
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Otsuka America Pharmaceutical, Inc..
Across 1 payment — averaging $124.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$125
What the payments were for
- Food & beverage$125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$125
How this compares
$125 in reported general payments places this provider in the 60th percentile of 90 geriatric medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $23,217 |
| JanuviaSitagliptin Phosphate | 14 | $7,953 |
| Rivastigmine | 12 | $2,953 |
| Donepezil Hcl | 28 | $1,635 |
| Atorvastatin Calcium | 79 | $981 |
| Gabapentin | 75 | $918 |
| Memantine Hcl | 26 | $871 |
| Azelastine Hcl | 22 | $811 |
| Metoprolol Succinate | 25 | $576 |
| Levothyroxine Sodium | 56 | $506 |
| Doxazosin Mesylate | 12 | $505 |
| Losartan Potassium | 33 | $481 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $477 |
| Nebivolol Hcl | 12 | $463 |
| Allopurinol | 21 | $282 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Newport News
- Jacob AlmeidaNewport News$337
- Hemal PatelNewport News$284
- Robert AckermanNewport News$172
- Steven GriswoldNewport News$60
- Stefan GravensteinNorfolk$306K
- Cara RavagliRoanoke$103K
- Jennifer JonkersAbingdon$8K
- Vijay ChadhaReston$7K
- Jiho ChoiAnnandale$5K
- Christopher WebbLynchburg$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.